| Entry |  | 
|---|
| Name |  | 
|---|
| Formula | CH4N2O
 | 
|---|
| Exact mass | 60.0324
 | 
|---|
| Mol weight | 60.06
 | 
|---|
| Structure |  
 | 
|---|
| Remark |  | 
|---|
| Reaction |  | 
|---|
| Pathway | | map00330 | Arginine and proline metabolism | 
 | map01110 | Biosynthesis of secondary metabolites | 
 | map01120 | Microbial metabolism in diverse environments | 
 | map05120 | Epithelial cell signaling in Helicobacter pylori infection | 
 | 
|---|
| Module | | M00546 | Purine degradation, xanthine => urea | 
 | 
|---|
| Network |  | 
|---|
| Enzyme |  | 
|---|
| Brite | Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]B BLOOD AND BLOOD FORMING ORGANS
 B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS
 B05B I.V. SOLUTIONS
 B05BC Solutions producing osmotic diuresis
 B05BC02 Carbamide
 D00023  Urea (JP18/USP) <JP>
 D DERMATOLOGICALS
 D02 EMOLLIENTS AND PROTECTIVES
 D02A EMOLLIENTS AND PROTECTIVES
 D02AE Carbamide products
 D02AE01 Carbamide
 D00023  Urea (JP18/USP) <JP>
 Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
 26  Epidermides
 266  Emollients
 2669  Others
 D00023  Urea (JP18/USP)
 Classification of Japanese OTC drugs [BR:br08313]
 Agents for integumentary system
 59 Skin emollient (incl. pus extrusion)
 D00023  Urea (JP18/USP)
 Risk category of Japanese OTC drugs [BR:br08312]
 Third-class OTC drugs
 Inorganic and organic chemicals
 Urea
 D00023  Urea (JP18/USP)
 Drug groups [BR:br08330]
 Dermatological agent
 DG03243  Atopic dermatitis agent
 D00023  Urea
 Drug classes [BR:br08332]
 Dermatological agent
 DG03243  Atopic dermatitis agent
 D00023  Urea
 Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
 D00023  Urea
 
 | 
|---|
| Other DBs |  | 
|---|
| LinkDB |  | 
|---|
| KCF data | ATOM        4
 1   C5a C    24.8500  -19.0400
 2   N1a N    23.6383  -19.7424
 3   N1a N    26.0617  -19.7424
 4   O5a O    24.8500  -17.6411
 BOND        3
 1     1   2 1
 2     1   3 1
 3     1   4 2
 
 | 
|---|